Neuroscience Archive

Laureen Kernan
A building with a stone facade displays a sign that reads
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Efficacy of TAK-755 in Acute Ischemic Stroke
A building with a stone facade displays a sign that reads
Post-market Safety and Effectiveness of the CORUS-LX System in Improving Lumbar Interbody Fusion Outcomes for the Treatment of Degenerative Lumbosacral Disc Disease.
A building with a stone facade displays a sign that reads
Post-market Safety and Effectiveness of the CORUS-LX System in Improving Lumbar Interbody Fusion Outcomes for the Treatment of Degenerative Lumbosacral Disc Disease.
A medical professional wearing a mask examines a chest X-ray image, holding it up to the light for closer inspection.
HonorHealth Research Institute patient receives new type of lumbar spine disc repair, alleviating pain and restoring range of motion
A building with a stone facade displays a sign that reads
A Phase 3, Multi-regional, Open-label, Randomized Study of Tirabrutinib vs Rituximab and Temozolomide in Participants With Relapsed/Refractory Primary Central Nervous System Lymphoma
HonorHealth Research Institute stroke patient is the first in Arizona to receive a new treatment to clear blocked blood vessels in the brain
A building with a stone facade displays a sign that reads
An Open-Label Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of a Single Dose of Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (GBS) (FORWARD Study)
Neuroscience Grateful Patient
A building with a stone facade displays a sign that reads
A Multicenter, Double-blinded, Placebo-controlled, Single Ascending Dose, Two-part, Randomized, Phase 2 Clinical Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BB-031 in Acute Ischemic Stroke Patients